In uence of cardiac dysfunction and systemic in ammation on pulmonary function and airway responsiveness in obese subjects Abstract Purpose: Obesity is associated with le ventricular diastolic dysfunction and altered heart rate variability, as well as pulmonary dysfunction. e relationship between asthma and cardiac dysfunction in severely obese subjects is unknown, although it has been hypothesized that cardiac dysfunction may contribute to increase airway hyper-responsiveness (AHR). is study aimed to determine if AHR is associated with le ventricular diastolic dysfunction and heart rate variability in severely obese subjects.
An increased prevalence of symptomatic asthma has been described in obese subjects, although how obesity could in uence the development or the clinical expression of AHR is still debated [1] [2] [3] [4] [5] [6] [7] [8] . Possible suggested mechanisms by which obesity can alter airway function include mechanical factors, increased in ammatory state, and in uence of co-morbid conditions such as diabetes, dyslipidemia and hypertension [9] [10] [11] [12] .
Lung function is altered in obesity, as shown by reduced functional residual capacity (FRC), reduced tidal volume (VT) and small airway closure during tidal breathing [9] . Both visceral and subcutaneous fat can contribute to reduce lung volume and can possibly increase airway responsiveness [10, 13] . Obesity may be considered a chronic in ammatory state, o en associated with increased markers of systemic in ammation [12] ; however, there is no strong evidence that the latter can signi cantly impact local airway in ammation [14] . It has been previously reported that asthma, in obese subjects, constituted a speci c phenotype and that there was a signi cant trend towards a lesser eosinophilic airway in ammatory pattern in severely obese subjects [15] . Several researchers have reported that asthma was more di cult to manage in obese subjects, particularly in severely obese patients, who showed a poorer response to asthma medications despite similar symptoms perception [16] [17] [18] [19] [20] . Furthermore, diabetes is commonly associated with obesity and a higher prevalence of insulin resistance has been found in obese children with asthma [21] [22] . ere is evidence that hyperinsulinemia can induce a hypercontractile smooth muscle phenotype [23] but the relationship between abnormal glucose metabolism and AHR is still unclear [23] [24] [25] .
It has also been suggested that altered cardiovascular function could in uence airway physiology [9] . Congestive heart failure may increase airway responsiveness, possibly by increasing airway wall water content [27] [28] [29] . Indeed, subtle pulmonary congestion associated with le ventricular diastolic dysfunction can possibly amplify peri-bronchial oedema, and exacerbate airway responsiveness by mechanisms such as bronchial/parenchymal uncoupling. Obesity is also associated with alteredheart rate variability (HRV) [28] [29] [30] . Subjects with atopic dermatitis, allergic rhinitis and asthma show autonomic imbalance as observed for other diseases related to atopy or allergy [31] [32] ; however, the relationship between asthma and HRV is unknown in severely obese subjects [33] . So far, no study has used an integrative approach using these parameters within the same group of patients. e primary outcome was to assess, using a comprehensive dataset, the determinants of the degree of airway responsiveness in light of the presence of le ventricular diastolic dysfunction, altered heart rate variability and metabolic parameters in severely obese patients. We hypothesized that in severely obese subjects, airway hyper-responsiveness (AHR) is associated with the presence of le ventricular diastolic dysfunction and altered HRV. We also hypothesized that the severity of AHR correlates with systemic in ammation and dysglycemia.
Methods

Study population
Sixty-one severely obese subjects (BMI ≥35kg/m 2 with comorbidities), aged 21 to 65 years, were enrolled from the Institut universitaire de Cardiologie et de pneumologie de uébec (IUCPQ) bariatric surgery program between October 2006 and June 2009. Subjects who were unable to provide informed consent, or who were pregnant or breast feeding, or had respiratory conditions (apart from AHR) that could interfere with the study design were excluded.
e subjects were preinterviewed by a physician from the bariatric surgery program and then contacted by our study group to take part of this study, which was approved by our Ethics Committee. All subjects signed an informed consent form.
Clinical Measurements
Anthropometric measures were recorded at the beginning of the study. Body weight was measured to the nearest 0.1 kg and height was measured to the nearest 0.01 meter. Body mass index (BMI) was calculated as body weight (kg) divided by height (m) squared (kg /m 2 ). Atopic status was determined from skin prick tests, performed using a battery of common airborne allergens. A complete blood count, fasting blood glucose, Apo-B, pro-NT-BNP, lipid pro le including total cholesterol concentration, high-density lipoprotein (HDL), lowdensity lipoprotein (LDL) and triglycerides as well as Creactive protein (CRP) concentrations were obtained [34] .
Forced expiratory volume in one second (FEV1) and forced vital capacity (FVC) were measured from ow-volume curves performed according to the American oracic Society (ATS) speci cations, using an ATS-approved spirometer [35] . Baseline FEV 1 was calculated as the best of the three reproducible values (with a maximum change of 5%). Predicted values were obtained from Knudson [36] . Methacholine challenge was performed according to the method described by Juniper et al. up to a concentration of 16 mg/ml [37] . Lung volume and carbon monoxide (CO) di using capacity were measured by standard procedures using body plethysmography [38] . Methacholine challenge and body plethysmography were performed on di erent days.
Echocardiographic measures were recorded with a commercial ultrasound system (Sonos 5500; Hewlett Packard, Andover, MA). Standard parasternal, short-axis and apical views were performed in accordance with the recommendations of the American Society of Echocardiography and the same observer, who was blinded to other study evaluations, assessed all recordings and measurements. Le ventricular diastolic dysfunction, using transmitral and pulmonary veins recordings, was evaluated according to well-standardized criteria as previously reported [39] [40] . HRV was derived from a 24-hour Holter monitoring system (Marquette Electronics., Milwaukee, WI) in all subjects during normal daily life activities. Numerous indices of HRV in the frequency and the time domains were determined: mean value of all RR intervals (mean NN), standard deviation of the RR intervals (SDNN), standard deviation of the mean NN intervals for each 5 minutes period (SDANN), square root of the mean squared di erence of successive RR intervals (rMSSD), percentage of di erences between adjacent normal RR intervals exceeding 50 ms (pNN50), high frequency (HF) and low frequency (LF) [40] .
Statistical methods
Data are expressed as mean ± SD for continuous variables or as percentage± SD for categorical data. Geometric mean was used for methacholine PC20. AHR was de ned as a provocative dose of methacholine inducing a 20% fall of FEV 1 < 8mg/ml (PC 20 <8 mg/ml). For statistical analysis, a PC 20 ≥16 mg/ml was considered as being equal to 16 mg/ml. Analyses of categorical variables were performed using the Fisher's exact test. According to the distribution of continuous data, Student's ttest or Wilcoxon's rank-sum test was used to compare groups. e normality assumption was veri ed with the Shapiro-Wilk test and the Brown and Forsythe's variation of Levene's test statistic was used to verify homogeneity of variances. e results were considered signi cant with p-values ≤ 0.05. e relationships between variables were expressed using the Pearson's correlation coe cient. e results were considered signi cant with p-values ≤0.05. Data were analyzed using the statistical package program SAS v8.2 (SAS Institute Inc., Cary, NC).!Data were analyzed using the statistical package program SAS v8.2 (SAS Institute Inc., Cary, NC).
Results
Sixty-two subjects agreed to take part in the study and sixtyone completed the study; one being excluded because of inability to perform all the tests. irty-two subjects su ered AHR (PC 20 <8 mg/ml) while 29 had normal airway responsiveness (PC 20 ≥ 8mg/ml).
Anthropometric data were similar in severely obese subjects with and without AHR as were subjects with atopy, smoking status and smoking history (Table 1) . Apart from AHR, obesity-related co-morbid conditions were comparable between groups (Table 2 ). In the group with AHR, 19/32 subjects (59.4%) had a physician-diagnosed or self-reported asthma compared to 8/29 (27.6%) in the group with normal airway responsiveness (p<0.001). Eleven subjects used daily bronchodilators in the hyper-responsive group compared to none in the normo-responsive group (p<0.001). e number of subjects regularly using inhaled corticosteroids was not signi cantly di erent between groups (Table 3) .
Blood measurements
Results of fasting blood glucose, lipid pro le and C-reactive protein levels are showed in Table 4 . e groups with and without AHR were similar for all parameters except for HDL level, which was higher in the hyper-responsive group (p = 0.03).
Methacholine challenge
Baseline FEV1 before methacholine inhalation was 86.6 ± 11.9% in the hyper-responsive group and 94.0 ±12.7% (p = 0.02) in the normo-responsive group. is signi cant di erence was not found, however, on baseline evaluation of lung function (Table 4) . Baseline FVC was 93.6 ± 13.3% and 98.7 ± 13.8%, respectively (p = 0.15). Mean airway responsiveness to methacholine was 1.7 mg/ml, ranging from 0.01 mg/ml to 7.6 mg/ml in the hyper-responsive group and 15.3 mg/ml (10.4 to ≥16 mg/ml) in the normo-responsive group.
Lung olumes and CO di usion
As expected, FEV1/FVC ratio (p = 0.02) and forced mid 25-75% expiratory ow (FEF Use of oral corticosteroid 0 0 -a : bd = bronchodilator Number of patients (%) and mean ± SD for age of asthma AHR: airway hyper-responsiveness PC20: provocative dose (of methacholine) inducing a 20% f diagnosis fall of FEV1 group compared with the normo-responsive group (Table 4) . FEV 1 and FVC were also slightly lower in the hyper-responsive group but there was no statistically signi cant di erence between groups. Carbon monoxide lung di using capacity (DLCO) was similar in both groups.
Cardio ascular measurements
Indices of HRV were similar in subjects with or without AHR (Table 5) . A higher number of subjects with AHR depicted a more severe degree of le ventricular diastolic dysfunction (grade 2) compared with subjects without AHR (p=0.037); however, the overall degree of cardiac dysfunction had no statistically signi cant in uence on the methacholine response ( Figure 1A ) or on CRP levels ( Figure 1B) .
Correlations
ere was a signi cant correlation between CRP levels and PC20 methacholine in the group of subjects with AHR (r = 0.38, p = 0.03, Figure 2 ). is could not be assessed in the normo-responsive group as most subjects had less than 20% fall in FEV 1 with a dose of methacholine of 16 mg/ml. Another analysis setting the cut-o at 4 mg/ml betweenween the two groups and another sub-analysis excluding subjects on inhaled 0.83 Mean ± SD, median and range for PC20: provocative dose (of metha AHR: airway hyper-responsiveness HBa1c: glycated hemoglobin HDL: high-density lipoprotein choles CRP: C-reactive protein, NT-Pro-PNB: pro-brain natriuretic pepti ity, FEF25-75: forced mid 25-75% expiratory ow, TLC: total lung ca capacity, DLCO: carbon dioxide lung di using capacity. 
Discussion
No signi cant in uence of HRV and le ventricular diastolic dysfunction, dysglycemia, and dyslipidemia on the prevalence or magnitude of AHR was found in severely obese subjects. In contrast, CRP, a marker of systemic in ammation, correlated , although weakly, with the latter. How obesity could in uence the development of AHR is still debated [1] [2] [3] [4] [5] [6] [7] [8] ; however, recent data suggest that there is a causal relationship between obesity and asthma [1, 8, 41] . AHR, in the obese subject, may represent a speci c phenotype with a particular pathophysiology and clinical presentation, somewhat di erent from « classical » asthma [1, 2, 16] . Obesity has been associated with altered cardiac function [28] [29] [30] ; however, the relationship between AHR and cardiac dysfunction are still unknown in severely obese subjects. is is the rst study investigating, using a comprehensive set of data, the relationship among asthma, obesity, metabolic variables, HRV and le ventricular diastolic dysfunction. Although severely obese subjects with AHR were found to have more common grade 2 LVDD compared with normo-responsive subjects, globally, altered cardiac dysfunction had no signi cant in uence on methacholine responsiveness.
Le ventricular diastolic dysfunction has been reported to be associated with HRV in subjects with diabetes [39] and impaired le ventricular diastolic function may contribute to increased pulmonary artery wedge pressure [43] [44] [45] [46] .
is, in turn, could slightly alter total lung perfusion as well as the distribution of pulmonary blood ow, which may induce relative pulmonary congestion. is pulmonary turgor may contribute to increase airway responsiveness. e distinctive pathophysiology of AHR in severely obese subjects may have been in uenced by le ventricular diastolic function as well as by the autonomic nervous system as evaluated with HRV. Our study does not support this hypothesis. Instead, we found that a high CRP level was associated with AHR in severely obese subjects. Although the clinical signi cance of this correlation is uncertain, it is in agreement with previous data demonstrating that low grade systemic in ammation is increased in obesity and is also associated with bronchial asthma, although its causal relationship with AHR is still debated [12, 14, 18, 20] .
Obese subjects are more likely to experience dyspnea and a discrepancy is more likely to be observed between perceived symptoms and asthma diagnosis. Previous studies have shown that approximately one-third of both obese and non-obese subjects with physician-diagnosed asthma did not have asthma when objectively assessed [47] and over-diagnosis of asthma was no more likely to occur among obese than non-obese subjects [48] . In our group of severely obese subjects, some had AHR but no asthma diagnosis while others with an asthma diagnosis or asthma medication showed negative tests for AHR, demonstrating the di culty of attributing respiratory symptoms only to asthma in this population -this has also been shown to be the case with heart failure [48] . Asthma control may be overestimated in obese subjects, their respiratory symptoms being attributed to obesity per se as the increased work of breathing generates respiratory symptoms. is stresses the need to perform pulmonary function tests in this population. No signi cant correlation was found between AHR and either dysglycemia or dyslipidemia. It has been proposed that changes in lipids and glucose metabolism could be associated with AHR in obese subjects [24, 25, 48, 49] ; however, reported associations were weak. It has been speculated that the pro-in ammatory state of insulin resistance can contribute to systemic in ammation, explaining the pathogenesis of AHR in obese subjects [50] . In comparison with other studies, the diagnosis of AHR in our study was established following both a positive methacholine challenge and respiratory symptoms instead of physician-made or self-reported diagnosis.
Our study has some limitations. is was a cross-sectional study, and therefore not designed to investigate changes in AHR over time. A second limitation could be the limited number of subjects; however, we used a comprehensive set of data that has been associated with AHR and we were able to document associations with parameters such as CRP and grade 2 le ventricular diastolic dysfunction. A third possible limitation is that the methacholine challenge was stopped at 16 mg/ ml in the normo-responsive group. For this reason, a PC20≥16 mg/ml was considered as equal to 16 mg/ml in statistical analysis.
Conclusion
In conclusion, subtle cardiac dysfunction, dysglycemia or dyslipidemia do not appear to be associated with airway responsiveness in severely obese subjects. e fact that a greater proportion of subjects with grade 2 le ventricular diastolic dysfunction had AHR deserves further investigation. 
